Literature DB >> 10716516

Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.

J A Cepeda, D Wilks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10716516     DOI： 10.1097/00002030-200002180-00022

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.

Authors:  Asha R Kallianpur; Todd Hulgan
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

Review 2.  AIDS and AIDS-treatment neuropathies.

Authors:  D Williams; A Geraci; D M Simpson
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 6.030

Review 3.  AIDS and AIDS-treatment neuropathies.

Authors:  Derek Williams; Anthony Geraci; David M Simpson
Journal:  Curr Pain Headache Rep       Date:  2002-04

4.  Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling.

Authors:  Ting Wu; Juan Zhang; Mingxing Geng; Shao-Jun Tang; Wenping Zhang; Jianhong Shu
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

5.  Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.

Authors:  Alice K. Pau
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.663
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.